Psychemedics Corporation (PMD) vs Precipio, Inc. (PRPO)

Psychemedics Corporation and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $40.4M against $15.7M — 2.6× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −10.9%. Precipio, Inc. has the higher net margin (−4.47% vs −9.45%) and the higher return on invested capital (−7.63% vs −31.4%). Across the 20 metrics below, Precipio, Inc. leads on 11 and Psychemedics Corporation on 9.

Valuation

Metric PMD PRPO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.80 1.41 4.37
P/B 3.05 2.59 3.06
Price to free cash flow 19.46 48.43 35.76
EV/EBITDA 77.29 122.01 24.35
EV/Sales 0.74 1.33 5.51
Earnings yield (11.99%) (2.99%) (1.89%)
Free cash flow yield 5.14% 2.06% (0.15%)

Profitability

Metric PMD PRPO Diagnostics & Research median
Gross margin 36.07% 44.11% 50.89%
Operating margin (9.62%) (5.68%) (8.57%)
Net margin (9.45%) (4.47%) (6.37%)
Free cash flow margin 4.02% 2.90% 0.00%
Return on equity (31.54%) (8.98%) (2.92%)
Return on assets (18.03%) (6.05%) (6.71%)
Return on invested capital (31.42%) (7.63%) 0.00%

Growth

Metric PMD PRPO Diagnostics & Research median
Revenue growth (TTM) (10.92%) 28.04% 7.69%
EPS growth (last fiscal year) 55.56% 92.15% 25.92%
Revenue growth, 5-year CAGR (12.18%) 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMD PRPO Diagnostics & Research median
Debt to equity 0.01 0.07 0.11
Current ratio 1.82 1.77 2.02
Net debt to EBITDA (7.26) (3.30) 0.70

Dividend

Metric PMD PRPO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric PMD PRPO Diagnostics & Research median
Market cap 15.70m 40.35m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack